Emory Transplant Center Performs Its First HIV to HIV Kidney Transplant

Made possible by the HIV Organ Policy Equity (HOPE) Act, Emory Transplant Center has performed its first HIV-positive kidney transplant from an HIV-positive deceased donor. Not only was this Emory’s first HIV to HIV kidney transplant, it is also the first of its kind in Georgia and the first HIV to HIV positive kidney transplant in 2017.

Emory and eight other centers nationwide are taking part in the HOPE in Action clinical trial — a prospective, pilot study to evaluate the safety of HIV-positive deceased donor solid organ transplants (kidney and liver) in HIV-positive recipients.

Stable HIV-infected adults with end-stage kidney disease who meet study-specific HIV criteria for organ transplantation will be offered enrollment in the study at Emory. Currently, Emory is enrolling participants for HIV-positive to HIV-positive kidney transplants, with a plan to include liver transplant patients in the near future.

“With 120,000 people on the wait list for a kidney transplant, and about 10,000 people living with HIV who are on dialysis, the HOPE Act gives us new opportunities to save more lives, rather than turning down organ donations from HIV-positive donors,” says Nicole Turgeon, MD, kidney transplant surgeon, Emory Kidney Transplant Program and principal investigator of this study at Emory.

“Patients living with HIV are living longer because their disease is now considered manageable with good antiretroviral therapies. This means we are seeing more patients who are HIV-positive in need of organ transplants. The HOPE Act ensures a greater number of people will receive the life-saving transplant they need,” explains Turgeon.

The HOPE Act was enacted in November 2013, but did not become effective until November 2015. In 2016, 20 patients at four different centers received new organs in the HOPE in Action clinical trial. Research shows that HIV-positive transplant recipients have similar patient survival rates and kidney and liver graft survival rates post-transplant as non-HIV-positive recipients. This is good news for patients with HIV who need a transplant.

“We thank this donor and the donor’s family for giving life to others during their time of sorrow, and the excellent work of Life Link of Georgia that made this transplant possible,” says Turgeon. “We want to encourage others, with or without HIV, to register to be organ donors and to tell their families of their decision to help others. Go to Donate Life of Georgia to learn more.”

Learn more about the Emory Kidney Transplant Program.

Related articles


Recent posts

How Telehealth Can Help You: A Message from the Emory Transplant Center

If you haven’t used telehealth yet, what’s stopping you? It’s a convenient, easy way to receive the high-quality care you have come to expect...

Choose the 3Ws

There’s a lot of coronavirus information coming our way. And, aside from everyday changes, this information sometimes seems both conflicting and unclear. Despite all the...

Ablation Procedures Treat Varicose Veins Without Traditional Surgery

In the not too distant past, the only way to treat varicose veins was with surgery. Now, Emory Vein Center offers many alternatives that...

How Emory Transplant Center is Keeping Your Safety First

Emory Transplant Center is committed to your safety and well-being—especially now, when COVID-19 has created so much concern in our communities. We want you...

Emory Brain Health Center Offering Telehealth Appointments through Emory Connected Care

Since the beginning of the COVID-19 pandemic, the use of telehealth has played an important role in patient care throughout the Brain Health Center...